Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Indian Madder Root (Rubia cordifolia) contains bioactive anthraquinones—purpurin, rubiadin, munjistin, and the naphthoquinone mollugin—that inhibit JAK-STAT signaling, suppress pro-inflammatory cytokines (IL-1β, IL-6), and scavenge free radicals, conferring hepatoprotective, anti-inflammatory, and antioxidant effects. A comprehensive review by Shan et al. (2016) in Molecules documented over 100 identified compounds from Rubiae Radix et Rhizoma with demonstrated pharmacological activities including anti-tumor, antimicrobial, and anti-inflammatory properties (PMID: 27999402).
Reported Benefits (Provisional)
Origin & History
Indian Madder Root (Rubia cordifolia), known as Manjistha, is a perennial herb native to India and Southeast Asia, thriving in well-drained, loamy soils. Its vibrant red roots are traditionally prized for their detoxifying and complexion-enhancing properties in various ancient medicinal systems.
Research Narrative (Provisional)
A major review by Shan et al. (2016) published in Molecules cataloged the botany, phytochemistry, pharmacology, and toxicology of Rubiae Radix et Rhizoma, identifying over 100 compounds including anthraquinones, naphthoquinones, and cyclopeptides with anti-inflammatory, hepatoprotective, and antimicrobial activities (PMID: 27999402). Gopinath (2020) in the Indian Journal of Dermatology, Venereology and Leprology explored the dermatological relevance of plant-derived pigments including those from Rubia species, noting their traditional use in skin conditions (PMID: 33037162). Yockey et al. (2017) in Chemical Research in Toxicology investigated the mechanism of DNA replication past lucidin-derived DNA damage, highlighting important genotoxicity considerations for certain anthraquinone constituents found in madder root (PMID: 28972744). Zuo et al. (2020) in Pharmacological Research assessed heavy metal contamination risks in Chinese herbal medicines including Rubiae Radix, underscoring the importance of quality control and sourcing (PMID: 32512044).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Anthraquinones: Alizarin, purpurin, and rubiadin, known for detoxifying and anti-inflammatory effects. - Flavonoids: Kaempferol, providing antioxidant protection. - Glycosides: Contribute to its therapeutic properties. - Triterpenoids: Support anti-inflammatory responses. - Calcium: Essential for bone health and cellular function.
Reported Mechanism (Provisional)
Mollugin, a key naphthoquinone in Indian Madder Root, inhibits nitric oxide (NO) release by suppressing inducible nitric oxide synthase (iNOS) expression and blocks JAK2 phosphorylation, preventing downstream activation of STAT1 and STAT3 transcription factors, thereby reducing expression of pro-inflammatory cytokines IL-1β and IL-6. Anthraquinones such as purpurin and rubiadin act as potent free radical scavengers, chelating transition metal ions and interrupting lipid peroxidation chain reactions to protect hepatocyte membranes and cellular structures from oxidative damage. Munjistin and related hydroxyanthraquinones modulate NF-κB signaling and inhibit cyclooxygenase-2 (COX-2) activity, contributing to broad-spectrum anti-inflammatory effects. Additionally, alizarin-type anthraquinones promote bile flow (choleretic effect) by stimulating hepatobiliary transporter activity, supporting the root's traditional use in liver detoxification.
Clinical Narrative (Provisional)
Animal studies show Indian Madder Root extract at 400 mg/kg increases antioxidant enzymes (SOD, CAT, GST) to control group levels in cyclophosphamide-treated rats. In vitro studies demonstrate mollugin's anti-inflammatory effects at 7.5-30 μM concentrations in RAW264.7 macrophages. Anti-mutagenic studies report 70.71% reduction in mutagen-induced revertants with IC50 of 500 μg/0.1 ml. Human clinical trials validating traditional uses for skin health and detoxification are limited and emerging.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.